Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Condition:   Head and Neck Cancer Interventions:   Radiation: Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy);   Radiation: Proton Stereotactic Body Radiation Therapy (SBRT) (3-5 fractions; various dose and fractionation regimens depending on treatment site).;   Drug: Nivolumab 3 mg/kg IV q2 weeks;   Radia tion: Proton or Photon SBRT (3-5 fractions; various dose and fractionation regimens depending on treatment site). Sponsor:   Mayo Clinic Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials